Nanotechnology in Cancer: an Overview on
Importance of Patient’s Screening in
Nanomedicine Based Combinational Therapies
Volume 1 - Issue 3
Subodh Kumar, Phulen Sarma, Rahul Soloman Singh, Dibbanti Harikrishna Reddy, Sukhjinder Singh, Ashutosh
Singh and Bikash Medhi*
-
Author Information
Open or Close
- Department of Pharmacology, PGIMER, India
*Corresponding author:
Bikash Medhi, Department of Pharmacology, PGIMER, Chandigarh, India, 160012
Received: May 12, 2018; Published: May 29, 2018
DOI: 10.32474/ANOAJ.2018.01.000112
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Targeting cancer using nanomedicine is not a new concept. Earlier focus was on targeted therapy and then concept came of
combinational therapy. Along with the use of combinational therapies, Pre-selection screening of the patients using molecular
approach is equally important to achieve the maximum benefit to the cancer patients.
Keywords: Nanotechnology; Nanomedicine; Cancer; Combinational Therapy; Biological Systems; Liposomal Formulations;
Targeting Tumors; Cardiomyopathy; Solid Tumors; Meta-Analysis
Abstract|
Mini Review|
Nanotechnology and Nanomedicine|
Conclusion|
References|